# Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis

> **NCT03053388** · PHASE3 · COMPLETED · sponsor: **Beyond Air Inc.** · enrollment: 69 (actual)

## Conditions studied

- Bronchiolitis

## Interventions

- **DRUG:** Nitric Oxide
- **OTHER:** Supportive treatment

## Key facts

- **NCT ID:** NCT03053388
- **Lead sponsor:** Beyond Air Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-05
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-04-28
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053388, "Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03053388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*